Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Latest advances in antibody delivery mediated by rAAV for treatment of chronic and infectious diseases

Research finding could set stage for potential development of new antimicrobial drugs

Research finding could set stage for potential development of new antimicrobial drugs

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Researchers use DNA markers to differentiate harmless species from deadly bacteria

Researchers use DNA markers to differentiate harmless species from deadly bacteria

Tgen-NAU researchers produce anthrax genome sequence from victims of 1979 outbreak

Tgen-NAU researchers produce anthrax genome sequence from victims of 1979 outbreak

Scientists fabricate smart second skin to protect soldiers from biological and chemical threats

Scientists fabricate smart second skin to protect soldiers from biological and chemical threats

FDA approves safety labeling changes for fluoroquinolone antibiotics

FDA approves safety labeling changes for fluoroquinolone antibiotics

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Scientists explain how engineered anthrax toxin proteins could help eliminate cancerous tumors

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

New drug-capture device can soak up chemotherapy drugs to limit toxicity

New drug-capture device can soak up chemotherapy drugs to limit toxicity

Guardian system can predict risk of dangerous diseases

Guardian system can predict risk of dangerous diseases

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Discoveries could lead to development of novel therapies to prevent C. diff infection

Discoveries could lead to development of novel therapies to prevent C. diff infection

PharmAthene to be compensated for loss of profits over SIGA's smallpox antiviral drug

PharmAthene to be compensated for loss of profits over SIGA's smallpox antiviral drug

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

Rutgers scientists uncover biological pathways that provide insight into tiny cell bubbles

Rutgers scientists uncover biological pathways that provide insight into tiny cell bubbles

Containing airborne contaminants: an interview with Gary Broomhead, Cantel Medical

Containing airborne contaminants: an interview with Gary Broomhead, Cantel Medical

BioThrax approved to prevent disease after exposure to anthrax spores

BioThrax approved to prevent disease after exposure to anthrax spores

TGen receives 2015 Regents' Award for Outstanding Service to Higher Education

TGen receives 2015 Regents' Award for Outstanding Service to Higher Education